Unadjusted | Adjusteda | |||||
---|---|---|---|---|---|---|
Characteristics | CommLink n (%) | SLS n (%) | CommLink % (95% CI) | SLS % (95% CI) | RR (95% CI) | p-value |
ART initiated by 90 days of diagnosisb | ||||||
Sex | ||||||
Men | 390 (88.8) | 111 (34.8) | 86.5 (85.1, 88.0) | 33.7 (27.3, 41.5) | 2.57 (2.08, 3.17) | < 0.0001 |
Women | 309 (92.5) | 191 (42.4) | 90.5 (88.3, 92.7) | 41.2 (34.7, 48.9) | 2.20 (1.83, 2.65) | < 0.0001 |
Age group (years) | ||||||
15–24 | 106 (93.0) | 61 (33.3) | 90.9 (85.2, 97.0) | 32.2 (25.7, 40.3) | 2.83 (2.28, 3.51) | < 0.0001 |
25–34 | 301 (89.3) | 138 (38.0) | 86.9 (83.8, 90.1) | 36.8 (30.3, 44.8) | 2.36 (1.92, 2.90) | < 0.0001 |
≥ 35 | 292 (90.7) | 103 (46.2) | 88.9 (85.7, 92.3) | 44.1 (34.3, 56.7) | 2.02 (1.58, 2.58) | < 0.0001 |
Test location (CommLink ART eligibility period)c | ||||||
Urban (CD4 ≤ 500) | 195 (78.6) | 110 (43.8) | 78.6 (76.5, 80.9) | 43.9 (40.9, 47.0) | 1.79 (1.72, 1.87) | < 0.0001 |
Rural (test and treat) | 504 (96.0) | 192 (37.1) | 96.2 (94.9, 97.4) | 37.1 (31.6, 43.6) | 2.59 (2.20, 3.04) | < 0.0001 |
ART initiated and retained by 18 months of diagnosisb,d | ||||||
Sex | ||||||
Men | 343 (78.1) | 145 (45.5) | 75.4 (66.2, 85.9) | 44.5 (37.9, 52.2) | 1.70 (1.39, 2.07) | < 0.0001 |
Women | 269 (80.5) | 243 (54.0) | 79.8 (75.5, 84.3) | 55.1 (49.4, 61.4) | 1.45 (1.24, 1.69) | < 0.0001 |
Age group (years) | ||||||
15–24 | 82 (71.9) | 81 (44.3) | 73.3 (68.8, 78.2) | 45.1 (36.9, 55.3) | 1.62 (1.35, 1.95) | < 0.0001 |
25–34 | 260 (77.2) | 178 (49.0) | 76.9 (72.4, 81.8) | 48.9 (41.6, 57.4) | 1.57 (1.32, 1.88) | < 0.0001 |
≥ 35 | 270 (83.9) | 129 (57.8) | 84.8 (80.7, 89.1) | 57.4 (47.7, 69.0) | 1.48 (1.18, 1.85) | 0.0007 |
Test location (CommLink ART eligibility period)c | ||||||
Urban (CD4 ≤ 500) | 186 (75.0) | 141 (56.2) | 72.8 (66.5, 79.8) | 55.4 (52.1, 59.0) | 1.31 (1.13, 1.53) | 0.0005 |
Rural (test and treat) | 426 (81.1) | 247 (47.7) | 78.4 (76.0, 80.9) | 47.0 (41.0, 53.9) | 1.67 (1.45, 1.93) | < 0.0001 |